Abstract-Studies have reported that development of congestive heart failure is associated with increased endoplasmic reticulum stress. Double stranded RNA-activated protein kinase R-like endoplasmic reticulum kinase (PERK) is a major transducer of the endoplasmic reticulum stress response and directly phosphorylates eukaryotic initiation factor 2α, resulting in translational attenuation. However, the physiological effect of PERK on congestive heart failure development is unknown. To study the effect of PERK on ventricular structure and function, we generated inducible cardiac-specific PERK knockout mice. Under unstressed conditions, cardiac PERK knockout had no effect on left ventricular mass, or its ratio to body weight, cardiomyocyte size, fibrosis, or left ventricular function. However, in response to chronic transverse aortic constriction, PERK knockout mice exhibited decreased ejection fraction, increased left ventricular fibrosis, enhanced cardiomyocyte apoptosis, and exacerbated lung remodeling in comparison with wild-type mice. PERK knockout also dramatically attenuated cardiac sarcoplasmic reticulum Ca
C ongestive heart failure (CHF) is a major cause of morbidity and mortality in developed countries and is a major threat to human health worldwide. CHF development is often associated with cardiomyocyte hypertrophy and increased protein synthesis. Protein synthesis and translation initiation are repressed during stress by phosphorylation of eukaryotic translation initiation factor 2 on the α subunit (eIF2α) of serine residue 51 (Ser51). 1 Phosphorylation of eIF2α Ser51 takes place via 4 known eIF2α protein kinases: protein kinase R (PKR), general control nonderepressible-2 (GCN2), heme-regulated Inhibitor kinase, and PKR-like endoplasmic reticulum kinase (PERK). PERK is activated under conditions of endoplasmic reticulum (ER) stress. Phosphorylation of eIF2α
Ser51 is thought to be a protective mechanism to attenuate translation under stress conditions. Interestingly, we identified that the eIF2α protein kinase, PKR, is increased in myocardium of patients with CHF and in mice with CHF. 2 Deletion of the PKR gene (knockout) markedly attenuated transverse aortic constriction (TAC)-induced CHF in mice. 2 In addition, we demonstrated that genetic disruption of the eIF2α protein kinase GCN2 also significantly attenuated TAC-induced CHF in mice. 3 However, the effect of eIF2α protein kinase PERK on TAC-induced CHF is unknown.
Various cellular stresses, including ischemia, hypoxia, oxidative stress, inflammation, and protein synthesis overload, lead to impaired protein folding and accumulation of unfolded proteins in the lumen of the ER. When unfolded protein levels exceed the protein folding capacity of the ER, an unfolded protein response (UPR) is activated, which induces expression of ER chaperones, activation of PERK, and phosphorylation of eIF2α
Ser51 to attenuate protein synthesis. While transient activation of the UPR is important for decreasing the protein load on the ER to restore ER homeostasis, extended activation of the UPR creates a state termed ER stress that can result in promotion of proapoptotic pathways mediated by proteins such as caspases and the CCAAT-enhancer-binding protein (or C/EBP) homologous protein (CHOP). 4, 5 In mammalian cells, the UPR is also mediated by ER transmembrane proteins inositol-requiring protein-1 and activating transcription factor 6 (ATF6). 6 Recently, several studies have demonstrated that development of CHF is associated with increased ER stress, [7] [8] [9] increased phosphorylation of PERK, [7] [8] [9] and increased phosphorylation of translation initiation factor eIF2α. 3, 10, 11 Because global PERK knockout causes growth retardation in mice, 12 we generated an inducible cardiomyocyte-specific PERK gene knockout model (designated PERK knockout). We examined the effect of PERK knockout on ventricular structure and function under control conditions (unstressed) and in response to pressure overload generated by TAC. In brief, under control conditions, PERK knockout had no detectable effect on left ventricular (LV) structure and function in mice. In contrast, PERK knockout profoundly exacerbated TAC-induced CHF and ventricular remodeling, indicating that PERK is dispensable for normal cardiac function under control conditions. However, PERK seems necessary for physiological adaptation to cardiac stress imposed by chronic pressure overload.
Materials and Methods
An extended Materials and Methods section can be found in the online-only Data Supplement.
Animals and Experimental Protocol
The experimental studies in mice were approved by the Institutional Animal Care and Use Committee at the University of Minnesota. /α-MHC MerCreMer and PERK flox/flox were given 4-hydroxytamoxifen (Sigma) at 20 mg/kg per day for 12 intraperitoneal injections. TAC procedures were further performed in female wild-type mice and PERK knockout mice as previously described.
Generation of Inducible Cardiomyocyte-Specific PERK Knockout Strain
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Results
Cardiomyocyte-Specific PERK Knockout Had No Effect on Cardiac Structure and Function in Mice Under Control Conditions
Because global PERK gene knockout mice exhibit growth defects, an inducible cardiomyocyte-specific PERK knockout strain was generated to determine the role of PERK in cardiac function ( Figure 1A ; Figure S1A in the online-only Data Supplement). To confirm the efficacy of cardiac-specific PERK gene deletion, adult cardiomyocytes were isolated from cardiomyocyte PERK knockout mice and control wild-type mice ≈4 weeks after the last injection of 4-hydroxytamoxifen. Western blot demonstrated that PERK expression was largely abolished in cardiomyocytes isolated from cardiac-specific PERK knockout mice without affecting PERK expression in other organs such as lung and liver (Figure S1B-S1D), indicating that cardiomyocyte-specific deletion of PERK was achieved. Echocardiography demonstrated that inducible cardiac-specific PERK knockout for 3 months had no detectable effect on heart rate, LV enddiastolic diameter, LV end-systolic diameter, LV wall thickness at both end diastole and end systole, and LV ejection fraction in mice ( Figure S2A-S2C ). PERK knockout also had no detectable effect on LV weight, left atrial (LA) weight, lung weight, right ventricular weight, right atrial weight, and their ratios to body weight in both male and female mice (Figure S2D-S2H; Table  S1 ). LV hemodynamics, measured in male PERK knockout and wild-type mice under control conditions, showed that PERK knockout had no detectable effect on mean aortic pressure, LV pressure, LV dP/dtmax and LV dP/dtmin ( Figure S3A-S3D ).
PERK Knockout Exacerbated TAC-Induced Cardiac Remodeling and Increase of Lung Weight in Female Mice
Because PERK knockout had no detectable effect on LV structure and function in both male and female mice under control conditions, we further studied the effect of PERK knockout on TAC-induced LV hypertrophy and dysfunction in a group of female mice. TAC-induced increase in LV systolic pressure results in LV hypertrophy and dysfunction. The LV dysfunction causes an increase in LV diastolic pressure that leads to LA hypertrophy, lung remodeling, and ultimately right ventricular hypertrophy or dysfunction. 14, 16 Therefore, TAC-induced CHF can be objectively evaluated by the progressive development of LA hypertrophy, pulmonary congestion, and right ventricular hypertrophy. 16 TAC-induced mortality rate was similar in wildtype and PERK knockout mice ( Figure S4 ). PERK knockout significantly exacerbated TAC-induced LV hypertrophy, LA hypertrophy, and pulmonary congestion, as indicated by significant increases of LV weight, LA weight, lung weight, and their ratios to body weight ( Figure S5 ; Figure 1B-1D ; Table  S2 ). TAC for 5 weeks caused a greater increase of right ventricular weight in PERK knockout mice compared with wild-type mice ( Figure 1E ). TAC also caused a greater increase of right atrial weight and its ratios to body weight in PERK knockout mice compared with wild-type mice ( Figure 1F ).
PERK Knockout Exacerbated TAC-Induced LV Dysfunction in Female Mice
Serial echocardiography showed that PERK knockout mice exhibited significantly greater LV end-systolic diameter and LV enddiastolic diameter in response to TAC compared with wild-type mice. Serial echocardiography also revealed a significant decline in LV ejection fraction in PERK knockout mice compared with wild-type littermates at 5 weeks after TAC (Figure 2A-2C ). TAC caused a significant increase of LV posterior wall thickness at end systole in both wild-type and PERK knockout mice ( Figure 2D ). This increase was significantly less in PERK knockout mice ( Figure 2D ), consistent with the greater contractile dysfunction in these mice. TAC caused a similar increase of LV posterior wall thickness at end diastole in both cohorts but had no effect on heart rate ( Figure 2E and 2F). It should be mentioned that our pilot study in a small number of male mice also showed that PERK knockout tended to exacerbate TAC-induced LV hypertrophy and dysfunction (data not shown).
PERK Knockout Exacerbated TAC-Induced LV Fibrosis and Cardiomyocyte Hypertrophy in Female Mice
Histological examination demonstrated that PERK knockout had no impact on LV cardiomyocyte size or LV fibrosis under control conditions. Morphological analysis showed evidence of LV fibrosis, LV perivascular fibrosis, and cardiomyocyte hypertrophy in both wild-type and PERK knockout hearts in response to TAC. The increases in LV fibrosis and myocyte cross-sectional area were significantly greater in PERK knockout hearts ( Figure S6A-S6E ).
PERK Knockout Exacerbated TAC-Induced Increase of Myocardial Apoptosis in Female Mice
Cardiomyocyte death and replacement fibrosis are features of pathological hypertrophy that cause LV dysfunction. A recent study suggested that PERK activation attenuates apoptosis in endothelial cells exposed to ER stress. 17 To examine whether PERK influences cardiomyocyte susceptibility to apoptosis under pressure overload conditions, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining was performed. Although PERK knockout had no effect on cardiac apoptosis under control conditions, the TAC-induced increase of apoptotic cells was significantly higher in PERK knockout hearts ( Figure S7A and S7B), a finding that is conceptually consistent with the previous report. 17 The increased apoptosis in PERK knockout mice was associated with a significant increase of cleaved caspase-3 and total caspase-3 content in these hearts after TAC ( Figure S8 ). Cleaved caspase-3 and total caspase-3 contents were also increased in PERK knockout mice under control conditions ( Figure S8 ).
PERK Knockout Exacerbated TAC-Induced Decrease of Sarcoplasmic Reticulum Ca 2+ ATPase in Female Mice
To examine the impact of PERK knockout in development of CHF further, Western blots were performed to examine expression of LV sarcoplasmic reticulum Ca 2+ ATPase Figure 2 . Protein kinase R-like endoplasmic reticulum kinase (PERK) knockout (KO) exacerbated transverse aortic constriction (TAC)-induced left ventricular (LV) dysfunction in mice. LV ejection fraction, LV dimensions, LV wall thickness, and heart rates were assessed using echocardiography before TAC and after 2 and 5 weeks of TAC in mice. Echocardiography shows the differences in LV end-systolic diameter (A), LV end-diastolic diameter (B), LV ejection fraction (C), LV wall thickness at end systole (D), LV wall thickness at end diastole (E), and heart rates (F) of wild-type and PERK KO mice after 5 weeks TAC. n=15 each group. *P<0.05 compared with before TAC; #P<0.05 compared KO mice to wild-type mice.
by guest on August 30, 2017 http://hyper.ahajournals.org/ Downloaded from (Serca2a), atrial natriuretic peptide (ANP), and β-myosin heavy chain, 3 commonly used biochemical markers for LV dysfunction. As anticipated, Cre is expressed only in PERK knockout mice. The Cre expression was significantly reduced after TAC ( Figure 3A and 3B). Under control conditions, PERK knockout did not affect LV Serca2a, ANP, or β-myosin heavy chain expression ( Figure 3A-3E ). In response to TAC, Serca2a (often reduced in CHF) 14, 18 was dramatically reduced in PERK knockout mice compared with wild-type mice ( Figure 3A and 3E). ANP and β-myosin heavy chain were elevated in both wild-type and PERK knockout mice after TAC, yet the increases were significantly greater in PERK knockout mice ( Figure 3 ). Expression of ANP mRNA also increased significantly more in PERK knockout mice after TAC than in WT mice ( Figure 3F ). Serca2a function is controlled, in part, by the regulatory protein phospholamban (PLB). Thus we further examined protein levels of PLB, as well as its phosphorylation on Ser16. PERK knockout hearts exhibited increased phosphorylation of PLB Ser16 (at 25 kDa) under control conditions. TAC caused a significant increase of myocardial p-PLB Ser16 in wild-type mice, whereas the increase of p-PLB Ser16 was largely diminished in PERK knockout mice ( Figure S9 ). PERK knockout mice also exhibited significantly greater reduction of myocardial PLB content in response to TAC compared with wild-type mice ( Figure S9 ).
PERK Knockout Exacerbated TAC-Induced Lung Remodeling in Female Mice
We previously reported that LV dysfunction causes severe lung fibrosis and lung vascular remodeling, 3, 16 which is anticipated to exacerbate the progression of CHF. Therefore, we examined TAC-induced lung fibrosis and lung vascular remodeling in wild-type and PERK knockout mice ( Figure S10A-S10D ). The percentage of nonmuscularized (with no apparent muscle), partially muscularized (with only a crescent of muscle), and fully muscularized (with a complete medial coat of muscle) small arteries in lung tissues was not different between wild-type and PERK knockout mice under control conditions. TAC caused an increase in fully muscularized small arteries in both wild-type and PERK knockout mice, but the number of fully muscularized small arteries was significantly greater in the PERK knockout mice compared with wild-type mice ( Figure S10C ). Similarly, both wild-type and PERK knockout mice exhibited a significant decrease in nonmuscularized small arteries, yet the number of nonmuscularized small arteries was significantly reduced in PERK knockout compared with wildtype mice ( Figure S10C ), indicating that PERK knockout significantly exacerbated TAC-induced lung vascular remodeling. As anticipated, lung fibrosis was not affected in PERK knockout mice under control conditions but was significantly exacerbated in PERK knockout lungs compared with wild-type lungs in response to TAC ( Figure S10 ; Figure S11 ).
PERK Knockout Attenuated TAC-Induced Phosphorylation of eIF2α
Ser51
PERK is activated in response to elevated levels of misfolded proteins in the ER. On activation, PERK phosphorylates eIF2α Ser51 , which represses translation initiation to lessen the protein load in the ER. Therefore, we examined the impact of PERK knockout on eIF2α
Ser51 phosphorylation in the heart. Interestingly, no difference was observed in eIF2α
Ser51 phosphorylation between WT and PERK knockout mice under basal conditions. However, PERK knockout significantly attenuated TAC-induced increase of eIF2α
Ser51 phosphorylation in the heart ( Figure 4A and 4B), suggesting that the ability to repress translation in response to cardiac ER stress was impaired.
Glucose-Regulated Proteins 78kDa and 94kDa and CHOP Expression Were Increased in PERK Knockout Heart After TAC
Glucose-regulated protein 78kDa (GRP78) and 94kDa (GRP94) are chaperones that promote protein folding and are upregulated under conditions of ER stress. 19 Expression levels of myocardial GRP78 and GRP94 were unchanged in PERK knockout mice under control conditions (Figure 4) . Interestingly, although expression levels of GRP78 and GRP94 were increased in both wild-type and PERK knockout hearts in response to TAC, expression of these chaperone proteins was significantly greater in PERK knockout hearts. CHOP is a transcription factor upregulated by prolonged ER stress 20 and is thought to promote apoptosis in several disease models, including heart failure. 21 Although CHOP is undetectable in wild-type and knockout hearts under control conditions, expression of CHOP was significantly elevated in PERK knockout mice in response to TAC compared with wild-type mice ( Figure 4A and 4B). These data suggest that disruption of PERK exacerbates ER stress. TAC also caused significant increase of ATF4 in wild-type hearts, but surprisingly, ATF4 expression was not attenuated by PERK knockout ( Figure  S12 ), suggesting that PERK is not required for induction of ATF4 in the overloaded heart. ATF6 expression was also not affected in PERK knockout mice under control conditions or after TAC ( Figure S12 ).
Discussion
The major finding in this study is that cardiomyocyte-specific disruption of the eif2α kinase PERK exacerbated development of CHF in mice exposed to hemodynamic overload. Disruption of PERK expression in cardiomyocytes had no observable effect on cardiac structure or function under control conditions but exacerbated pathological hypertrophy in response to TAC, as indicated by greater ventricular mass with decreased function and more ventricular dilation and fibrosis. This was accompanied by higher expression of cardiac stress markers ANP and β-myosin heavy chain. PERK knockout hearts also exhibited increased apoptosis and a dramatic reduction of Serca2a in response to TAC, suggesting that PERK is important for cardiomyocyte survival and maintenance of intracellular calcium homeostasis during adaptation to pressure overload. Combining this work in the context of our previous findings showing that loss of the eIF2α protein kinases, GCN2, as well as PKR, also significantly attenuated TAC-induced CHF, our findings suggest that each of these 3 eIF2α kinases exerts unique effects on cardiac function in mice in response to systolic pressure overload.
Interestingly, we observed a significant reduction of Serca2a expression in PERK knockout mice exposed to TAC. Serca2a is a well-defined therapeutic target for treating CHF and important regulator of calcium homeostasis in cardiomyocytes. 18 ER calcium depletion resulting from reduced Serca2a activity can induce ER stress. 22 Thapsigargin, an inhibitor of Serca2a activity, 23 is commonly used to induce ER stress. In the heart, exogenous expression of Serca2a has been shown to attenuate ER stress and CHF in mouse myocardial infarction or pressure overload models, 24 whereas selective Serca2a gene deletion in cardiomyocytes causes ER stress in cardiomyocytes and promotes CHF. 10 However, attenuation of ER stress was found to preserve Serca2a expression and cardiomyocyte function in an obesity model, 25 suggesting that ER stress and impaired ER calcium handling aggravate one another. A recent study has also demonstrated that PERK knockout disrupts intracellular calcium homeostasis and insulin secretion in β-cells by modulating Serca2a activity, 26 a finding that is consistent with the present study. The dramatic reduction in LV Serca2a protein expression in PERK knockout after TAC is anticipated to exacerbate ER stress in these mice further. Because Serca2a activity is critical for maintaining cardiac function, the dramatic Serca2a reduction in PERK knockout mice after TAC is likely an important mechanism for the exacerbated CHF in these mice.
PERK, ATF6, and Ire1 are the 3 most well-recognized components of the ER stress-sensing system and together play a critical role in maintaining ER function during cell adaptation to stress. Under basal conditions, these transmembrane ER proteins are bound by the chaperone protein GRP78, which maintains them in an inactive state. Under conditions that increase misfolded protein content in the ER, GRP78 binds misfolded proteins and releases from the ER stress sensors, resulting in their activation. 27 While ATF6 and Ire1 activation can directly upregulate UPR gene mRNA transcription 28 or processing, 29 PERK helps relieve ER stress by inhibiting translation initiation through direct phosphorylation of eif2α Ser51 , thereby decreasing the protein load on the ER. 30, 31 The finding that cardiomyocyte-specific PERK knockout did not alter UPR gene expression or phosphorylation of eif2α Ser51 under basal conditions, and had no observable effect on cardiac structure or function under basal conditions, suggests misfolded proteins do not accumulate under control conditions at levels sufficient to activate PERK. UPR genes GRP78, GRP94, and CHOP were significantly upregulated in both wild-type and PERK knockout mice in response to TAC, consistent with previous studies demonstrating increased ER stress in the failing heart. 9, 10, 21 The finding that UPR gene expression was higher in PERK knockout hearts suggests that ER stress was exacerbated by PERK disruption. The somewhat surprising finding that ATF4 expression was not reduced while CHOP expression was increased in PERK knockout hearts suggests other components of the ER stress-sensing machinery may be hyperactivated in absence of PERK. In support of a role for PERK-dependent translational repression during cardiomyocyte ER stress, phosphorylation of eif2α
Ser51 was increased by TAC in wild-type hearts, yet this increase was significantly phosphorylation may have contributed to ER stress by increasing protein overload in the ER. Together these findings indicate that ER stress signaling to UPR genes such as GRP78, GRP94, and CHOP can occur independent of PERK and that cardiac ER stress is further elevated by PERK knockout, possibly as a collective effect of reduced myocardial Serca2a expression and unabated translation during ER stress.
Although GRP78 and GRP94 are markers of the UPR that protect against ER stress by improving protein folding, 19 CHOP is an ER stress-induced transcription factor that is generally thought to promote apoptosis under conditions of prolonged ER stress. 32 CHOP expression is increased in the failing heart, 9,10,21 whereas CHOP gene deletion attenuates TAC-induced myocardial oxidative stress and heart failure 21 and also reduces oxidative stress in β-cells in diabetes mellitus. 33 The increased CHOP expression and LV fibrosis in PERK knockout hearts after TAC may contribute to the LV dysfunction observed in PERK knockout mice by increasing both apoptosis and cardiomyocyte oxidative stress. The elevated TAC-induced fibrosis observed after specific disruption of PERK in cardiomyocytes may be because of replacement fibrosis from increased cardiomyocyte death, as well as reactive fibrotic response to increased necrosis and inflammation resulting from Serca2a depletion. In addition to preserving Serca2a activity and limiting ER stress, PERK may also exert cardiac protective effects through modulating additional molecular pathways implicated in CHF development. A recent study demonstrated that PERK activation can induce cardiomyocyte autophagy, 34 an evolutionary stress response that is important for adaptation to cardiac stress. 35, 36 PERK is one of the 4 eIF2α kinases that phosphorylate eIF2α at Ser51 in response to different types of stress. PKR responds to viral infection, inflammation, ER stress, and nutrient signals. GCN2 is mainly activated during amino acid starvation and nutrient deficiency, and heme-regulated inhibitor kinase limits protein synthesis in heme-deficient cells. We have recently demonstrated that genetic knockout of eIF2α kinase GCN2 significantly attenuated TAC-induced cardiac dysfunction and cardiac eIF2α phosphorylation in mice, 3 whereas knockout of eIF2α kinase PKR markedly attenuated TAC-induced cardiac dysfunction without affecting cardiac eIF2α phosphorylation. 2 Interestingly, both GCN2 knockout and PKR knockout had no detectable effect on TAC-induced LV hypertrophy. In the present study, PERK knockout significantly exacerbated TAC-induced LV hypertrophy and CHF but attenuated cardiac eIF2α phosphorylation in mice. These studies demonstrate that each of these 3 eIF2α kinases exerts unique effects on cardiac function in mice in response to systolic pressure overload. Although inhibition of PKR and GCN2 may be effective in protecting the heart against CHF development in response to pressure overload, enhancing PERK signaling may be effective in attenuating CHF development.
Perspectives
eIF2α kinase PERK plays an important role in sensing ER stress. Studies have demonstrated that CHF is associated with increased ER stress, but the impact of PERK on CHF development was not known. Our study provides the first direct evidence that inhibition of PERK activity by PERK gene deletion in the heart exacerbates the development of CHF and lung remodeling, indicating that PERK sensing of ER stress in cardiomyocytes is important in protection against development of CHF.
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Materials and Methods
TAC procedure. TAC procedure was performed as previously described [3] [4] . Briefly, the mice are anesthetized with a mixture of 80 mg/kg ketamine and 30 mg/kg xylazine (i.p.). A horizontal incision 5 mm in length is made at the level of the suprasternal notch to allow direct access to the transverse aorta. TAC is performed by ligating the aorta between the right innominate artery and the left carotid artery over a 27-gauge needle using 5.0 silk suture. The needle is then quickly removed, leaving the constriction in place. Final studies were performed at 5 weeks after TAC.
Echocardiography and evaluation of LV hemodynamics:
Mouse echocardiographic images were obtained with a Visualsonics high-resolution Veve 660 or 770 system as previously described. 1 For aortic and left ventricular (LV) pressure measurement, a 1.2-F pressure catheter (Scisense Inc) was introduced through the right common carotid artery into the ascending aorta and then advanced into the LV for measurement of end-diastolic pressures and positive and negative LV rate of pressure development (dP/dt) after the mouse was anesthetized with 2% isoflurane [3] [4] .
Sample collection, and Western blots: Mouse heart samples for protein analysis were flash frozen in liquid nitrogen, weighed on an electronic balance and stored in liquid nitrogen until transfer into a -80°C freezer. All samples were stored in a -80°C freezer until use. Mouse samples for histological analysis were fixed in formaldehyde at room temperature and embedded in paraffin blocks.
For western blot, samples of the LV were lysed in complete RIPA buffer (10mM Tris-HCl pH 7.4, 150mM NaCl, 1% NP40, 0.1% sodium dodecyl sulfate (SDS), 1mM phenylmethylsulfonyl fluoride (PMSF), 1x PhosStop and 1x protease inhibitor cocktail (Roche)) and homogenized by Sonic Dismembrator 100 (Fisher Scientific). The protein concentration of tissue homogenates was measured using Bio-Rad Protein Assay, and equal amounts of soluble protein were separated on 12% polyacrylamide gels, transferred onto nitrocellulose membrane, and followed by routine western blot analysis.
Quantitative RT-PCR:
For quantitative real-time PCR, total RNA from mouse LV was extracted using Trizol reagent (Invitrogen), and 2 μg of total RNA was used for reverse transcription reaction using Reverse Transcription & cDNA Synthesis Kit-Advantage RT for PCR Kit (Clontech Laboratories) followed by quantitative PCR using FastStart Universal SYBR Green Master (Rox) (Roche Applied Science). Primer pairs used in this study are listed in Supplementary Table 2 . The relative amount of each gene in each sample was estimated by the ∆∆C T method. Results were normalized to ribosomal RNA levels.
Histological staining: Heart sections were stained with Sirius Red (Sigma) for fibrosis, and FITC conjugated wheat germ agglutinin (Invitrogen) to evaluate myocyte size. For mean myocyte size, the cross-sectional areas of at least 120 cells per sample and at least 5 samples per group were averaged. The relative pulmonary vascular muscularization was determined under H&E staining. In each mouse, over 60 intra-acinar arteries were examined and categorized as nonmuscular (NM, with no apparent muscle), partially muscular (PM, with only a crescent of muscle) or fully muscular (FM, with a complete medial coat of muscle). The relative percentage of NM, PM and FM arteries was calculated. Lung fibrosis was determined using Masson's Trichrome staining. Lung fibrosis was stained using Modified Masson's Trichrome Stain Kit from Scy Tek laboratories. Quantification was done by dividing the area of blue staining by the total measured tissue section area in digitized images. Samples from 8 mice were analyzed per group.
Apoptotic cells were determined by TUNEL staining using the In Situ Cell Death Detection Kit (Roche) following the manufacturer's instructions. Data was quantified in 3000 nuclei from 10 random fields per heart. The summarized results were expressed as TUNEL positive nuclei per 1000 nuclei. Fibrosis was determined by Trichrome Stain Kit (Modified Masson's) (ScyTek Laboratories). Quantification was done by dividing the area of blue staining by the total measured LV section area in digitized images. Samples from three mice were analyzed per group.
Statistical Analysis: Normal distribution of data was determined by use of a normality test (Shapiro-Wilk) provided by SigmaPlot. If mouse physiological data were not normally distributed, the data were presented as median (quartiles), and followed by Nonparametric test (Mann-Whitney rank sum test). If data were normally distributed, the data were presented as mean±SEM. The Student t test was used to test for differences between 2 groups. Twoway ANOVA followed by a Bonferroni correction post hoc test was used to test for differences among >2 groups. The null hypothesis was rejected at P<0.05. Table S1 . Anatomic data for WT and PERK KO mice under control conditions. 
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